Incidence and computed tomography findings of lenvatinib-induced pancreatobiliary inflammation-Reference-Cited by-同舟云学术

Incidence and computed tomography findings of lenvatinib-induced pancreatobiliary inflammation

Published:2021-09-03 Issue:35 Volume:100 Page:e27182
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Kurokawa Ryo,Inui Shohei,Tanishima Tomoya,Nakaya Moto,Kurokawa Mariko,Ishida Masanori,Gonoi Wataru,Amemiya Shiori,Nakai Yousuke,Ishigaki Kazunaga,Tateishi Ryosuke,Koike Kazuhiko,Abe Osamu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin;Ramakrishnan;Am J Hematol,2012

2. A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine;Fleeman;BMC Cancer,2019

3. Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer;Cabanillas;Semin Oncol,2019

4. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial;Kudo;Lancet,2018

5. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer;Schlumberger;N Engl J Med,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Development of Lenvatinib-Induced Pancreatitis in a Patient with Metastatic Neuroendocrine Tumor: A Case Report;Case Reports in Oncology;2023-04-20

2. A Case of Emergent Surgery for Acute Acalculous Cholecystitis during Lenvatinib Therapy;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2023

3. Efficient multiple treatments including molecular targeting agents in a case of recurrent hepatocellular carcinoma, post-living donor liver transplantation;Clinical Journal of Gastroenterology;2022-05-30

4. Cholecystitis and cholangitis associated with lenvatinib: A pharmacovigilance study;British Journal of Clinical Pharmacology;2022-02-09

5. Drug-induced bile duct injury: new agents, new mechanisms;Current Opinion in Gastroenterology;2021-12-20